share_log

康方生物：董事會會議召開日期

AKESO: DATE OF BOARD MEETING

HKEX ·  Aug 16 18:00
Summary by Futu AI
康方生物科技（開曼）有限公司（「本公司」）將於2024年8月28日（星期三）召開董事會會議，主要目的是考慮及批准截至2024年6月30日止六個月的中期業績報告及其發布。會議將由主席兼執行董事夏瑜博士主持，並有其他執行董事李百勇博士、王忠民博士、張鵬博士，非執行董事謝榕剛先生，以及獨立非執行董事曾駿文博士、徐岩博士及TAN Bo先生參與。該會議的通知於2024年8月16日由康方生物發出。
康方生物科技（開曼）有限公司（「本公司」）將於2024年8月28日（星期三）召開董事會會議，主要目的是考慮及批准截至2024年6月30日止六個月的中期業績報告及其發布。會議將由主席兼執行董事夏瑜博士主持，並有其他執行董事李百勇博士、王忠民博士、張鵬博士，非執行董事謝榕剛先生，以及獨立非執行董事曾駿文博士、徐岩博士及TAN Bo先生參與。該會議的通知於2024年8月16日由康方生物發出。
Akeso Biopharma (Cayman) Limited (the “Company”) will hold a Board of Directors meeting on Wednesday, August 28, 2024 to consider and approve the interim performance report for the six months ending June 30, 2024 and its publication. The meeting will be chaired by Dr. Xia Yu, Chairman and Executive Director, and attended by other Executive Directors, Dr. Li Baiyong, Dr. Wang Zhongmin, Dr. Zhang Peng, non-executive director Mr. Xie Ronggang, and independent non-executive directors Dr. Zeng Junwen, Dr. Xu Yan and Mr. Tan Bo. The notice of the meeting was issued by Akeso Biopharma on August 16, 2024.
Akeso Biopharma (Cayman) Limited (the “Company”) will hold a Board of Directors meeting on Wednesday, August 28, 2024 to consider and approve the interim performance report for the six months ending June 30, 2024 and its publication. The meeting will be chaired by Dr. Xia Yu, Chairman and Executive Director, and attended by other Executive Directors, Dr. Li Baiyong, Dr. Wang Zhongmin, Dr. Zhang Peng, non-executive director Mr. Xie Ronggang, and independent non-executive directors Dr. Zeng Junwen, Dr. Xu Yan and Mr. Tan Bo. The notice of the meeting was issued by Akeso Biopharma on August 16, 2024.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.